V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20166964 | 20063779 | 1.74 | 82.8 | Adjuvant (A) | 2018-10-25 | 2018-11-15 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100920729 |
| 20166965 | 20063780 | 1.73 | 55.05 | Curative (C) | 2017-12-09 | 2017-12-16 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100757219 |
| 20166966 | 20063781 | 1.62 | 96 | Adjuvant (A) | null | 2016-03-28 | ECX | N | null | ECX | 101855665 |
| 20166969 | 20063782 | 1.49 | 56.5 | Palliative (P) | 2019-11-28 | 2019-12-06 | ECX | 2 | N | ECX | 100921163 |
| 20166972 | 20063783 | 1.63 | 70.8 | Palliative (P) | 2019-12-26 | 2020-01-05 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100781396 |
| 20166984 | 20063784 | 1.67 | 90 | Adjuvant (A) | 2017-02-25 | 2017-03-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101709201 |
| 20166989 | 20063785 | 1.72 | 74 | Palliative (P) | 2018-09-24 | 2018-10-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100564488 |
| 20166993 | 20063786 | 1.69 | 65 | Not known (9) | 2017-08-20 | 2017-08-27 | ECX | 2 | N | ECX | 100887078 |
| 20166995 | 20063787 | 1.62 | 89.5 | null | 2019-12-04 | 2019-12-12 | ECX | N | null | ECX | 101454609 |
| 20166997 | 20063788 | 1.7 | 72 | Neo-adjuvant (N) | 2018-10-12 | 2018-10-12 | ECX | N | null | ECX | 101172597 |
| 20166998 | 20063789 | 1.65 | 58.7 | Palliative (P) | 2016-10-18 | 2016-10-25 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100432685 |
| 20167005 | 20063790 | 1.74 | 90 | null | 2016-12-17 | 2016-12-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101770302 |
| 20167010 | 20063791 | 1.88 | 126.9 | Neo-adjuvant (N) | 2018-06-09 | 2018-07-08 | ECX | N | N | ECX | 101155149 |
| 20167013 | 20063792 | 1.73 | 87.6 | Palliative (P) | 2018-06-01 | 2018-06-13 | ECX | N | N | ECX | 100570295 |
| 20167030 | 20063793 | 1.85 | 79 | Palliative (P) | 2018-01-23 | 2018-01-23 | ECX | 02 | N | ECX | 100169289 |
| 20167031 | 20063794 | 1.61 | 92.4 | Curative (C) | 2020-04-05 | 2020-04-20 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101744827 |
| 20167032 | 20063795 | 1.54 | 51.2 | null | 2017-03-25 | 2017-04-22 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100366054 |
| 20167039 | 20063796 | 1.5 | 97.5 | Adjuvant (A) | 2017-01-04 | 2017-01-20 | ECX | N | N | ECX | 100289598 |
| 20167040 | 20063797 | 1.72 | 77.1 | Palliative (P) | 2019-11-27 | 2019-12-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101635373 |
| 20167049 | 20063798 | 1.57 | 41.8 | Curative (C) | 2018-09-21 | 2018-09-23 | ECX | 2 | N | ECX | 101290565 |
| 20167050 | 20063799 | 1.7 | 63 | Neo-adjuvant (N) | 2019-06-13 | 2019-06-18 | ECX | N | N | ECX | 100764057 |
| 20167051 | 20063800 | 1.71 | 87.1 | Palliative (P) | 2017-02-08 | 2017-02-12 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101144050 |
| 20167052 | 20063801 | 1.7 | 83 | Neo-adjuvant (N) | 2019-09-11 | 2019-09-18 | ECX | N | N | ECX | 100817845 |
| 20167053 | 20063802 | 1.67 | 85.7 | Neo-adjuvant (N) | 2018-05-17 | 2018-05-25 | ECX | 02 | N | ECX | 101106281 |
| 20167055 | 20063803 | 1.57 | 56.5 | null | null | 2016-11-18 | ECX | N | N | ECX | 101814377 |
| 20167056 | 20063804 | 1.68 | 57.7 | Adjuvant (A) | 2017-02-08 | 2017-03-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101767181 |
| 20167061 | 20063805 | 1.76 | 78.7 | Palliative (P) | 2017-09-30 | 2017-10-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100079912 |
| 20167062 | 20063806 | 1.58 | 58 | Neo-adjuvant (N) | 2017-08-29 | 2017-09-08 | CAPECITABINE + GEMCITABINE | null | N | ECX | 100830747 |
| 20167064 | 20063807 | 1.71 | 65.75 | Neo-adjuvant (N) | 2016-03-24 | 2016-04-05 | ECX | 02 | N | ECX | 101360877 |
| 20167068 | 20063808 | 1.62 | 54.5 | Adjuvant (A) | 2017-08-15 | 2017-09-07 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100702762 |
| 20167072 | 20063809 | 1.54 | 60.6 | Palliative (P) | 2017-05-16 | 2017-05-16 | ECX | 02 | N | ECX | 101499789 |
| 20167075 | 20063810 | 1.72 | 70 | Adjuvant (A) | 2017-05-18 | 2017-05-20 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100886548 |
| 20167077 | 20063811 | 1.62 | 60.3 | Neo-adjuvant (N) | 2019-01-08 | 2019-01-12 | ECX | N | N | ECX | 101661027 |
| 20167081 | 20063812 | 1.42 | 53.6 | Neo-adjuvant (N) | 2018-09-17 | 2018-09-17 | ECX | N | N | ECX | 101253913 |
| 20167082 | 20063813 | 1.61 | 57 | null | 2016-03-26 | 2016-03-26 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 101869135 |
| 20167083 | 20063814 | 1.61 | 126 | Neo-adjuvant (N) | 2017-05-17 | 2017-06-05 | ECX | 02 | N | ECX | 101311754 |
| 20167086 | 20063815 | 1.71 | 87.3 | Neo-adjuvant (N) | null | 2019-05-10 | Gemcitabine + Capecitabine | N | N | ECX | 101014418 |
| 20167094 | 20063816 | 1.7 | 77.6 | Adjuvant (A) | 2017-03-31 | 2017-04-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100371155 |
| 20167101 | 20063817 | 1.8 | 71.4 | Palliative (P) | 2017-07-16 | 2017-07-28 | ECX | N | N | ECX | 101395179 |
| 20167110 | 20063818 | 1.58 | 49.8 | Adjuvant (A) | 2018-05-23 | 2018-05-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100673527 |
| 20167115 | 20063819 | 1.71 | 58 | Palliative (P) | 2017-03-14 | 2017-03-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100509388 |
| 20167117 | 20063820 | 1.61 | 47.5 | Adjuvant (A) | 2016-10-01 | 2016-10-14 | ECX | N | N | ECX | 101384936 |
| 20167124 | 20063821 | 1.7 | 68.3 | Adjuvant (A) | 2017-11-03 | 2017-12-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101092406 |
| 20167134 | 20063822 | 1.61 | null | Neo-adjuvant (N) | 2017-02-14 | 2017-02-26 | ECX | N | N | ECX | 100146408 |
| 20167137 | 20063823 | 1.6 | 77.6 | Neo-adjuvant (N) | 2017-01-01 | 2017-01-22 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 101038696 |
| 20167145 | 20063824 | 1.65 | 108.4 | Neo-adjuvant (N) | 2019-07-12 | 2019-07-16 | ECX | N | N | ECX | 100017988 |
| 20167150 | 20063825 | 1.75 | 78 | Palliative (P) | 2018-04-29 | 2018-04-29 | ECX | N | N | ECX | 100133723 |
| 20167154 | 20063826 | 1.68 | 55 | Adjuvant (A) | 2017-07-09 | 2017-07-11 | CAPECITABINE + GEMCITABINE | 2 | N | CAPECITABINE + GEMCITABINE | 100243353 |
| 20167158 | 20063827 | 1.64 | 89 | Adjuvant (A) | 2016-09-05 | 2016-09-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100224497 |
| 20167159 | 20063828 | 1.57 | 71.5 | Adjuvant (A) | 2019-11-30 | 2019-12-11 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100508600 |